FreeGuest Editorial Learning from suramin: A case study of NCI’s much-hyped cancer drug that crashed and burned—35 years ago August 09, 2019Vol.45 No.32By Cy Stein
Conversation with The Cancer LetterFree Indiana University Simon Cancer Center becomes 51st NCI-designated comprehensive cancer center August 06, 2019Vol.45 No.32By Matthew Bin Han Ong
Trials & Tribulations Barriers to clinical trial enrollmentPart I of a two-part series August 02, 2019Vol.45 No.31By Daniel Wall, Stephanie Engelien and Adedayo A. Onitilo
MD Anderson retains top spot on U.S. News rankings; Johns Hopkins moves up to No. 4 August 02, 2019Vol.45 No.31By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Sylvester becomes 71st NCI-designated cancer center July 29, 2019Vol.45 No.31By Paul Goldberg
Conversation with The Cancer Letter IASLC: The Lung Ambition Alliance will amplify initiatives in lung cancer on a global scale July 26, 2019Vol.45 No.30By Matthew Bin Han Ong
Lung Ambition Alliance seeks global partners to double lung cancer survival rates by 2025 July 26, 2019Vol.45 No.30By Matthew Bin Han Ong
Guest Editorial The cost of underfunding research and the lingering dread of unstable funding July 26, 2019Vol.45 No.30By Candace S. Johnson
Conversation with The Cancer Letter Zhang: St. Jude Cloud, world’s largest whole genome repository, is ready to test federated model July 26, 2019Vol.45 No.30By Matthew Bin Han Ong
NCI convenes key players to build framework for data federation in childhood cancer July 26, 2019Vol.45 No.30By Matthew Bin Han Ong
